Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage AI-driven precision oncology company leveraging its proprietary RADR ® artificial intelligence (AI) and machine learning (ML) platform to transform ...

Multidimensional analyses demonstrate that repeated DeltEx DRI dosing preserves immune function, drives tumor microenvironment remodeling, and ...

SAN DIEGO, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- via IBN -- Sapu Nano and Oncotelic (OTCQB: OTLC) today announced that the first patient has been dosed in the Phase 1b clinical trial of Sapu003, ...

Seer, Inc. ( SEER) Q1 2026 Earnings Call May 13, 2026 4:30 PM EDT Good day, and welcome to Seer First Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note this event is being ...

MRI based tumour microenvironment analysis improves biomarker discovery and non invasive profiling, achieving high accuracy ...

Seer (NASDAQ:SEER) reported lower first-quarter revenue but reaffirmed its full-year 2026 outlook, with management pointing ...

New home-based approach: Researchers developed a self-administered finger-prick blood test and online brain assessment to estimate Alzheimer’s risk without clinic visits. Biomarkers and cognition: The ...

Digital pathology and artificial intelligence are transforming the drug development landscape, accelerating the path to ...

Colorectal cancer (CRC) represents one of the most prevalent malignancies worldwide and remains a major contributor to global cancer morbidity and ...

Modern horticultural science operates at the intersection of plant metabolism, stress physiology, and quality trait development. As global environmental ...

QuartzBio was built to eliminate this friction. Its vendor-agnostic, AI-enabled platform unifies sample collection, chain of custody, consent status, metadata integrity, and biomarker results into a ...

For men with advanced prostate cancer that no longer responds to standard hormone therapies, treatment options are ...